Skip Ribbon Commands
Skip to main content

Below are our Top 12 2016 STI Publications. For a comprehensive list click here.

 

1.  Steroid Responsive Acute Rejection Should Not be the Endpoint for Immunosuppressive Trials.  Klintmalm GB, Vincenti F, Kirk A. Am J Transplant. 2016 May 27.

 

2.  The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E. Transplantation. 2016 Jan;100(1):39-53.

 

3.  2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-mediated Rejection. Demetris AJ, Bellamy C, Hübscher SG, O'Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M, Tanigawa RY, Yilmaz F, Alexander G, Baiocchi L, Balasubramanian M, Batal I, Bhan AK, Bucuvalas J, Cerski CT, Charlotte F, de Vera ME, ElMonayeri M, Fontes P, Furth EE, Gouw AS, Hafezi-Bakhtiari S, Hart J, Honsova E, Ismail W, Itoh T, Jhala NC, Khettry U, Klintmalm GB, Knechtle S, Koshiba T, Kozlowski T, Lassman CR, Lerut J, Levitsky J, Licini L, Liotta R, Mazariegos G, Minervini MI, Misdraji J, Mohanakumar T, Mölne J, Nasser I, Neuberger J, O'Neil M, Pappo O, Petrovic L, Ruiz P, Sağol Ö, Sanchez Fueyo A, Sasatomi E, Shaked A, Shiller M, Shimizu T, Sis B, Sonzogni A, Stevenson HL, Thung SN, Tisone G, Tsamandas AC, Wernerson A, Wu T, Zeevi A, Zen Y. Am J Transplant. 2016 Jun 7.

 

4.  Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients. Levitsky J, Verna EC, O'Leary JG, Bzowej NH, Moonka DK, Hyland RH, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault NA. N Engl J Med. 2016 Nov 24;375(21):2106-2108.

 

5.  Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience. O'Leary JG, Wong F, Reddy KR, Garcia-Tsao G, Kamath PS, Biggins SW, Fallon MB, Subramanian RM, Maliakkal B, Thacker L, Bajaj JS. Dig Dis Sci. 2016 Dec 26.

 

6.  Low measured hepatic artery flow increases the rate of biliary strictures in deceased donor liver transplantation: An age-dependent phenomenon. Kim PT, Fernandez H, Gupta A, Saracino G, Ramsay M, McKenna GJ, Testa G, Anthony T, Onaca N, Ruiz RM, Klintmalm GB. Transplantation. 2017 Feb; 101(2):332-340.

 

7.  MiR-375 and miR-200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation. Yoshimatsu G, Takita M, Kanak MA, Haque WZ C, Saravanan PB, Lawrence MC, Levy MF. J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):585-94.

 

8.  Belatacept and Long-Term Outcomes in Kidney Transplantation. Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. N Engl J Med. 2016 Jan 28;374(4):333-43. doi: 10.1056/NEJMoa1506027. Erratum in: N Engl J Med. 2016 Feb 18;374(7):698.

 

9.  An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection. Trotter JF. Hepatology. 2016 Nov 3.

 

10.  Ligating coronary vein varices: An effective treatment of "Coronary Vein Steal" to increase portal flow in liver transplantation. Gupta A, Klintmalm GB, Kim PT. Liver Transpl. 2016 Mar 30. 

 

11.  Contemporary extracorporeal membrane oxygenation therapy in adults: Fundamental principles and systematic review of the evidence. Squiers JJ, Lima B,  DiMaio JM. J Thorac Cardiovasc Surg. 2016;152(1):20-32.

 

12.  Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis. Modi AA,  Nazario H, Trotter JF, Gautam M, Weinstein J, Mantry P, Barnes M, Habib A, McAfee J, Teachenor O, Tujague L, Gonzalez S. Liver Transpl. 2016 Mar;22(3):281-6.